MAPT and Parkinson disease: This cross-sectional study of n = 41 individuals across the LBD spectrum (Parkinson’s disease + DLB) represents to our knowledge the first examination of 18F-PI-2620 tau PET in LBD and is one of the largest studies of tau PET imaging in LBD using any tau PET radiotracer.